What is Scanadu?
Scanadu operates at the intersection of medical technology and consumer wellness, providing a comprehensive platform for health-related insights. Through strategic partnerships with organizations like dualdiagnosis.org, the company delivers expert-led guides, product evaluations, and in-depth coverage of emerging medical innovations. Their service model is designed to empower individuals with actionable data, focusing on fitness, well-being, and specialized health topics. By leveraging a team of subject matter experts, Scanadu ensures that its content meets professional standards, effectively serving as a bridge between clinical-grade information and the everyday needs of health-conscious consumers.
How much funding has Scanadu raised?
Scanadu has raised a total of $59.9M across 6 funding rounds:
Unspecified
$2M
Other Financing Round
$4.2M
Angel/Seed
$1.7M
Series A
$10.5M
Series B
$35M
Private Equity
$6.5M
Unspecified (2011): $2M, investors not publicly disclosed
Other Financing Round (2011): $4.2M led by Luc De Vos and Starlight Ventures
Angel/Seed (2013): $1.7M, investors not publicly disclosed
Series A (2013): $10.5M featuring Mindful Investors, Relay Ventures, VegasTechFund, Redmile Group, LLC, and Broe Group
Series B (2014): $35M backed by Tencent Holdings Ltd., Fosun International Ltd., Relay Ventures, China Broadband Capital, AME Cloud Ventures, and IGlobe Partners
Private Equity (2016): $6.5M, investors not publicly disclosed
Key Investors in Scanadu
Tencent Holdings Ltd.
A global technology conglomerate that develops digital platforms and internet-based services, with a strong focus on investing in technology innovation and large-scale digital ecosystems.
Relay Ventures
An early-stage venture capital firm specializing in mobile computing software, providing founders with unparalleled networks and resources to disrupt incumbent industries.
AME Cloud Ventures
A venture fund led by Jerry Yang that focuses on infrastructure and value chains around data, supporting technology-heavy companies across the entire data stack.
What's next for Scanadu?
Looking ahead, the recent capital injection is expected to accelerate Scanadu's product development cycle and expand its reach within the global health-tech market. The company is well-positioned to leverage its existing data infrastructure to refine its diagnostic tools and enhance its digital service offerings. As the demand for personalized, accessible medical information continues to rise, Scanadu's strategic focus on integrating advanced technology with user-centric health platforms will likely remain a core driver of its long-term value proposition. Future initiatives will likely prioritize the scaling of its expert-led content ecosystem and the deepening of its technological capabilities to maintain a competitive edge in the rapidly evolving wellness sector.
See full Scanadu company page
